

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.79767207 |
| 2 | plasma membrane repair (GO:0001778) | 9.49485592 |
| 3 | * actin filament-based movement (GO:0030048) | 8.49815946 |
| 4 | sarcomere organization (GO:0045214) | 7.57570885 |
| 5 | * skeletal muscle fiber development (GO:0048741) | 7.31054849 |
| 6 | skeletal muscle adaptation (GO:0043501) | 7.29066396 |
| 7 | striated muscle contraction (GO:0006941) | 7.23435923 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.93731726 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.45902104 |
| 10 | myofibril assembly (GO:0030239) | 6.33328723 |
| 11 | response to inactivity (GO:0014854) | 6.25308286 |
| 12 | * myotube cell development (GO:0014904) | 6.15662912 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.07412091 |
| 14 | * muscle contraction (GO:0006936) | 5.83157770 |
| 15 | striated muscle atrophy (GO:0014891) | 5.59488969 |
| 16 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.49531992 |
| 17 | cytidine deamination (GO:0009972) | 5.41862705 |
| 18 | cytidine metabolic process (GO:0046087) | 5.41862705 |
| 19 | cytidine catabolic process (GO:0006216) | 5.41862705 |
| 20 | response to muscle activity (GO:0014850) | 5.37217782 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.35015972 |
| 22 | actomyosin structure organization (GO:0031032) | 5.34894038 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.29904719 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.24123697 |
| 25 | * muscle system process (GO:0003012) | 5.21670998 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.18860723 |
| 27 | positive regulation of myotube differentiation (GO:0010831) | 5.15787810 |
| 28 | NADH metabolic process (GO:0006734) | 5.15408809 |
| 29 | skeletal muscle tissue regeneration (GO:0043403) | 5.03636131 |
| 30 | myoblast fusion (GO:0007520) | 4.95900558 |
| 31 | creatine metabolic process (GO:0006600) | 4.91621265 |
| 32 | striated muscle adaptation (GO:0014888) | 4.85681825 |
| 33 | muscle atrophy (GO:0014889) | 4.82128690 |
| 34 | * muscle fiber development (GO:0048747) | 4.78010829 |
| 35 | muscle cell cellular homeostasis (GO:0046716) | 4.74059259 |
| 36 | cardiac muscle contraction (GO:0060048) | 4.69093815 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 4.67168658 |
| 38 | cardiac myofibril assembly (GO:0055003) | 4.58726219 |
| 39 | glycogen catabolic process (GO:0005980) | 4.57182255 |
| 40 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.48674257 |
| 41 | muscle cell fate commitment (GO:0042693) | 4.47998596 |
| 42 | striated muscle hypertrophy (GO:0014897) | 4.45795618 |
| 43 | syncytium formation by plasma membrane fusion (GO:0000768) | 4.44883774 |
| 44 | skeletal muscle tissue development (GO:0007519) | 4.44722809 |
| 45 | carnitine shuttle (GO:0006853) | 4.38658896 |
| 46 | muscle organ development (GO:0007517) | 4.38403982 |
| 47 | muscle organ morphogenesis (GO:0048644) | 4.34627931 |
| 48 | syncytium formation (GO:0006949) | 4.31816772 |
| 49 | muscle structure development (GO:0061061) | 4.30719917 |
| 50 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.28126086 |
| 51 | glucan catabolic process (GO:0009251) | 4.27638895 |
| 52 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.24344818 |
| 53 | regulation of relaxation of muscle (GO:1901077) | 4.23867054 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 4.23670730 |
| 55 | fructose metabolic process (GO:0006000) | 4.17847551 |
| 56 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.11818287 |
| 57 | muscle tissue morphogenesis (GO:0060415) | 4.11328394 |
| 58 | glucan biosynthetic process (GO:0009250) | 4.10947676 |
| 59 | glycogen biosynthetic process (GO:0005978) | 4.10947676 |
| 60 | positive regulation of myoblast differentiation (GO:0045663) | 4.06732398 |
| 61 | regulation of striated muscle contraction (GO:0006942) | 4.03623710 |
| 62 | muscle hypertrophy (GO:0014896) | 3.97497740 |
| 63 | * striated muscle cell development (GO:0055002) | 3.97121353 |
| 64 | cellular polysaccharide catabolic process (GO:0044247) | 3.95458132 |
| 65 | gluconeogenesis (GO:0006094) | 3.94561050 |
| 66 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.94481431 |
| 67 | muscle adaptation (GO:0043500) | 3.93921630 |
| 68 | adult heart development (GO:0007512) | 3.92739490 |
| 69 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.79889049 |
| 70 | polysaccharide catabolic process (GO:0000272) | 3.79566797 |
| 71 | cardiac muscle cell development (GO:0055013) | 3.78508341 |
| 72 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.74056051 |
| 73 | myotube differentiation (GO:0014902) | 3.71474162 |
| 74 | fatty acid transmembrane transport (GO:1902001) | 3.70766344 |
| 75 | negative regulation of muscle hypertrophy (GO:0014741) | 3.69352180 |
| 76 | purine nucleotide salvage (GO:0032261) | 3.62595147 |
| 77 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.61432186 |
| 78 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.61432186 |
| 79 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.61410300 |
| 80 | tricarboxylic acid cycle (GO:0006099) | 3.60017864 |
| 81 | neuronal action potential propagation (GO:0019227) | 3.57785017 |
| 82 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.56575102 |
| 83 | muscle hypertrophy in response to stress (GO:0003299) | 3.56575102 |
| 84 | cardiac muscle adaptation (GO:0014887) | 3.56575102 |
| 85 | cardiac cell development (GO:0055006) | 3.54534168 |
| 86 | negative regulation of protein localization to cell surface (GO:2000009) | 3.53178333 |
| 87 | hexose biosynthetic process (GO:0019319) | 3.52328008 |
| 88 | regulation of the force of heart contraction (GO:0002026) | 3.51352101 |
| 89 | regulation of myoblast differentiation (GO:0045661) | 3.51185845 |
| 90 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.49962816 |
| 91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.47536463 |
| 92 | * muscle cell development (GO:0055001) | 3.42935188 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 3.40912394 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.40625134 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.40625134 |
| 96 | negative regulation of muscle contraction (GO:0045932) | 3.40506069 |
| 97 | ubiquinone biosynthetic process (GO:0006744) | 3.40447420 |
| 98 | neuromuscular synaptic transmission (GO:0007274) | 3.39211413 |
| 99 | regulation of coenzyme metabolic process (GO:0051196) | 3.39122283 |
| 100 | regulation of cofactor metabolic process (GO:0051193) | 3.39122283 |
| 101 | regulation of membrane repolarization (GO:0060306) | 3.36485540 |
| 102 | striated muscle tissue development (GO:0014706) | 3.36443754 |
| 103 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.34100574 |
| 104 | glycogen metabolic process (GO:0005977) | 3.33531806 |
| 105 | regulation of sarcomere organization (GO:0060297) | 3.32626454 |
| 106 | response to activity (GO:0014823) | 3.32229456 |
| 107 | neuromuscular junction development (GO:0007528) | 3.28194916 |
| 108 | glucan metabolic process (GO:0044042) | 3.26771330 |
| 109 | cellular glucan metabolic process (GO:0006073) | 3.26771330 |
| 110 | regulation of actin filament-based movement (GO:1903115) | 3.22467578 |
| 111 | IMP metabolic process (GO:0046040) | 3.20242557 |
| 112 | carnitine transmembrane transport (GO:1902603) | 3.20056541 |
| 113 | regulation of muscle system process (GO:0090257) | 3.19231690 |
| 114 | regulation of myotube differentiation (GO:0010830) | 3.19101899 |
| 115 | heart contraction (GO:0060047) | 3.19093029 |
| 116 | heart process (GO:0003015) | 3.19093029 |
| 117 | regulation of muscle contraction (GO:0006937) | 3.15122142 |
| 118 | negative regulation of cell size (GO:0045792) | 3.14778317 |
| 119 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.12008017 |
| 120 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.11294295 |
| 121 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.09853536 |
| 122 | * muscle filament sliding (GO:0030049) | 13.8973782 |
| 123 | * actin-myosin filament sliding (GO:0033275) | 13.8973782 |
| 124 | skeletal muscle contraction (GO:0003009) | 11.7806171 |
| 125 | regulation of skeletal muscle contraction (GO:0014819) | 11.4725994 |
| 126 | * actin-mediated cell contraction (GO:0070252) | 11.3740719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.33397631 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.95864102 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.43461559 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.93991282 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.43144388 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.26436603 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05604463 |
| 8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.84944300 |
| 9 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.84944300 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.63602710 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.59923236 |
| 12 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.40549962 |
| 13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.24173141 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.20968358 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.17066489 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09378633 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.04988896 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.04963291 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94851519 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94079911 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.78032794 |
| 22 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75981888 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71599086 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67633032 |
| 25 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.65596873 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58916299 |
| 27 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.58749058 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58507349 |
| 29 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.57921103 |
| 30 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57651312 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56882324 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.54969227 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54488457 |
| 34 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.53494237 |
| 35 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.52639868 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48996580 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46752875 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46676917 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42217458 |
| 40 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.41771428 |
| 41 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40833055 |
| 42 | * TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39818647 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38875958 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38035565 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36736715 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36028675 |
| 47 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.35681436 |
| 48 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.34609276 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34554184 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31888093 |
| 51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.30972110 |
| 52 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.30653730 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28979467 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28903968 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27710361 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27587907 |
| 57 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.27109389 |
| 58 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26555382 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25469463 |
| 60 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.25076721 |
| 61 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.21441725 |
| 62 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21340920 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21239357 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21179106 |
| 65 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.19980479 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18919128 |
| 67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18564266 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18052559 |
| 69 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.17319206 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17074026 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15472171 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14724475 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14100877 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12782428 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12466052 |
| 76 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10118063 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08917444 |
| 78 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07156658 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06516013 |
| 80 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06315732 |
| 81 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.06162999 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05026746 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02633402 |
| 84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02401078 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01203673 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99000344 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97278999 |
| 88 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96907360 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96841585 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96592784 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 0.96246454 |
| 92 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96229052 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96122424 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95457003 |
| 95 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.95240568 |
| 96 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94775300 |
| 97 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94268383 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94087985 |
| 99 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.93785854 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93735695 |
| 101 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93704749 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92882099 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92318183 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91630968 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91081192 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90393706 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90035102 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89999428 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89855252 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89747554 |
| 111 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.89392067 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88995642 |
| 113 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88576726 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88391581 |
| 115 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.87889088 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85580352 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85143963 |
| 118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85017686 |
| 119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84124990 |
| 120 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84122270 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83918274 |
| 122 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83326399 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83257680 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81641981 |
| 125 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81558639 |
| 126 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.81407168 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.81365154 |
| 128 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81354199 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.80453246 |
| 130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80297280 |
| 131 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80281073 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80124228 |
| 133 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.79922811 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79647606 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79453869 |
| 136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75506201 |
| 137 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72723553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 6.87511594 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 6.64135417 |
| 3 | MP0000751_myopathy | 6.36402914 |
| 4 | MP0003646_muscle_fatigue | 5.07404147 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.40692581 |
| 6 | * MP0002106_abnormal_muscle_physiology | 4.05594520 |
| 7 | * MP0000747_muscle_weakness | 3.91981156 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.88909113 |
| 9 | MP0000750_abnormal_muscle_regeneration | 3.74036116 |
| 10 | * MP0000759_abnormal_skeletal_muscle | 3.71210792 |
| 11 | * MP0004087_abnormal_muscle_fiber | 3.61139125 |
| 12 | MP0002269_muscular_atrophy | 3.48430475 |
| 13 | * MP0005369_muscle_phenotype | 3.37391478 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.04237207 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.76600081 |
| 16 | MP0004130_abnormal_muscle_cell | 2.57229050 |
| 17 | MP0004233_abnormal_muscle_weight | 2.50042483 |
| 18 | * MP0000733_abnormal_muscle_development | 2.47192813 |
| 19 | MP0005330_cardiomyopathy | 2.45605485 |
| 20 | MP0002108_abnormal_muscle_morphology | 2.06875794 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.01908594 |
| 22 | MP0004270_analgesia | 1.96545380 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.82954071 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.73354796 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.68961889 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.58998512 |
| 27 | MP0004484_altered_response_of | 1.55645132 |
| 28 | MP0005275_abnormal_skin_tensile | 1.54449471 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.48681413 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.38561580 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.21076182 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.20671110 |
| 33 | MP0001544_abnormal_cardiovascular_syste | 1.16942023 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.16942023 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15225542 |
| 36 | * MP0002971_abnormal_brown_adipose | 1.13002132 |
| 37 | MP0003137_abnormal_impulse_conducting | 1.03399663 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.03185906 |
| 39 | MP0002822_catalepsy | 1.00766676 |
| 40 | MP0002234_abnormal_pharynx_morphology | 0.99767411 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 0.99109236 |
| 42 | MP0005375_adipose_tissue_phenotype | 0.95628358 |
| 43 | MP0005266_abnormal_metabolism | 0.91271872 |
| 44 | MP0001661_extended_life_span | 0.88224684 |
| 45 | MP0006138_congestive_heart_failure | 0.87447066 |
| 46 | MP0008775_abnormal_heart_ventricle | 0.87326594 |
| 47 | MP0004134_abnormal_chest_morphology | 0.75210445 |
| 48 | MP0001299_abnormal_eye_distance/ | 0.75174092 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 0.75120236 |
| 50 | MP0004510_myositis | 0.73729740 |
| 51 | MP0000762_abnormal_tongue_morphology | 0.72741401 |
| 52 | MP0005503_abnormal_tendon_morphology | 0.70231132 |
| 53 | MP0006035_abnormal_mitochondrial_morpho | 0.69727788 |
| 54 | MP0009250_abnormal_appendicular_skeleto | 0.67083732 |
| 55 | MP0003828_pulmonary_edema | 0.65485770 |
| 56 | MP0002127_abnormal_cardiovascular_syste | 0.64841601 |
| 57 | MP0000266_abnormal_heart_morphology | 0.63557048 |
| 58 | MP0002796_impaired_skin_barrier | 0.62699808 |
| 59 | MP0000003_abnormal_adipose_tissue | 0.61028611 |
| 60 | MP0005670_abnormal_white_adipose | 0.59939266 |
| 61 | MP0003879_abnormal_hair_cell | 0.56889899 |
| 62 | MP0004085_abnormal_heartbeat | 0.56150575 |
| 63 | MP0000343_altered_response_to | 0.54954167 |
| 64 | MP0001346_abnormal_lacrimal_gland | 0.54199220 |
| 65 | MP0000579_abnormal_nail_morphology | 0.52615659 |
| 66 | MP0003566_abnormal_cell_adhesion | 0.52283536 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.49857012 |
| 68 | MP0005623_abnormal_meninges_morphology | 0.44796968 |
| 69 | MP0008569_lethality_at_weaning | 0.44621723 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.44160740 |
| 71 | MP0003941_abnormal_skin_development | 0.43878044 |
| 72 | MP0000372_irregular_coat_pigmentation | 0.42359998 |
| 73 | MP0009780_abnormal_chondrocyte_physiolo | 0.42157710 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 0.41830118 |
| 75 | MP0003948_abnormal_gas_homeostasis | 0.41433647 |
| 76 | MP0001243_abnormal_dermal_layer | 0.41087318 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.40691131 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.40015140 |
| 79 | MP0004147_increased_porphyrin_level | 0.39034104 |
| 80 | MP0003045_fibrosis | 0.38310462 |
| 81 | MP0002249_abnormal_larynx_morphology | 0.38305342 |
| 82 | MP0002128_abnormal_blood_circulation | 0.38173055 |
| 83 | MP0003279_aneurysm | 0.37900642 |
| 84 | MP0005334_abnormal_fat_pad | 0.37638290 |
| 85 | MP0002638_abnormal_pupillary_reflex | 0.37519065 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.37281726 |
| 87 | MP0005501_abnormal_skin_physiology | 0.37209508 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.37049560 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.36857790 |
| 90 | * MP0002114_abnormal_axial_skeleton | 0.36338141 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36186106 |
| 92 | MP0005166_decreased_susceptibility_to | 0.36108104 |
| 93 | MP0003385_abnormal_body_wall | 0.35955166 |
| 94 | MP0010030_abnormal_orbit_morphology | 0.35606772 |
| 95 | MP0005083_abnormal_biliary_tract | 0.35321493 |
| 96 | MP0005535_abnormal_body_temperature | 0.35127675 |
| 97 | MP0004142_abnormal_muscle_tone | 0.35022290 |
| 98 | MP0004272_abnormal_basement_membrane | 0.34360715 |
| 99 | * MP0002078_abnormal_glucose_homeostasis | 0.34019152 |
| 100 | MP0002060_abnormal_skin_morphology | 0.33984305 |
| 101 | MP0003959_abnormal_lean_body | 0.32532259 |
| 102 | MP0009672_abnormal_birth_weight | 0.31246487 |
| 103 | * MP0005452_abnormal_adipose_tissue | 0.30406551 |
| 104 | MP0001943_abnormal_respiration | 0.30369343 |
| 105 | MP0005332_abnormal_amino_acid | 0.28978926 |
| 106 | MP0004043_abnormal_pH_regulation | 0.27687566 |
| 107 | MP0001542_abnormal_bone_strength | 0.27028285 |
| 108 | MP0005451_abnormal_body_composition | 0.26923025 |
| 109 | MP0005165_increased_susceptibility_to | 0.26091267 |
| 110 | MP0009115_abnormal_fat_cell | 0.25828035 |
| 111 | MP0001849_ear_inflammation | 0.25766798 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.25216263 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.24806598 |
| 114 | MP0002066_abnormal_motor_capabilities/c | 0.21306037 |
| 115 | MP0005423_abnormal_somatic_nervous | 0.21085502 |
| 116 | MP0005187_abnormal_penis_morphology | 0.19808482 |
| 117 | MP0004858_abnormal_nervous_system | 0.17423440 |
| 118 | MP0006276_abnormal_autonomic_nervous | 0.15370232 |
| 119 | MP0009840_abnormal_foam_cell | 0.13717563 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.12877806 |
| 121 | MP0008874_decreased_physiological_sensi | 0.11959884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Muscle fiber inclusion bodies (HP:0100299) | 9.68375975 |
| 2 | * Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.35759951 |
| 3 | * Nemaline bodies (HP:0003798) | 8.73779210 |
| 4 | Distal arthrogryposis (HP:0005684) | 7.93854159 |
| 5 | * Type 1 muscle fiber predominance (HP:0003803) | 7.47189900 |
| 6 | Exercise-induced myalgia (HP:0003738) | 7.08793655 |
| 7 | Round ear (HP:0100830) | 6.69450174 |
| 8 | Ulnar deviation of the wrist (HP:0003049) | 6.42799259 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 6.30482619 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.87274888 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 5.63849579 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.57120466 |
| 13 | * Myopathic facies (HP:0002058) | 5.45573014 |
| 14 | Muscle fiber splitting (HP:0003555) | 5.35923251 |
| 15 | Deformed tarsal bones (HP:0008119) | 5.13530289 |
| 16 | Difficulty running (HP:0009046) | 4.94884469 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.93361497 |
| 18 | Fetal akinesia sequence (HP:0001989) | 4.89395390 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.88524290 |
| 20 | Malignant hyperthermia (HP:0002047) | 4.77894905 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 4.48038353 |
| 22 | Increased connective tissue (HP:0009025) | 4.34520248 |
| 23 | * EMG: myopathic abnormalities (HP:0003458) | 4.19863096 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 4.11713627 |
| 25 | Myoglobinuria (HP:0002913) | 3.97928704 |
| 26 | Increased variability in muscle fiber diameter (HP:0003557) | 3.86197129 |
| 27 | Popliteal pterygium (HP:0009756) | 3.76249461 |
| 28 | Difficulty climbing stairs (HP:0003551) | 3.63460097 |
| 29 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 3.62911691 |
| 30 | Abnormality of the neuromuscular junction (HP:0003398) | 3.61365841 |
| 31 | Fatigable weakness (HP:0003473) | 3.61365841 |
| 32 | * Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.56938633 |
| 33 | Muscle stiffness (HP:0003552) | 3.49904409 |
| 34 | Myotonia (HP:0002486) | 3.46165892 |
| 35 | Abnormality of the calcaneus (HP:0008364) | 3.42647317 |
| 36 | * Neck muscle weakness (HP:0000467) | 3.34876865 |
| 37 | Rhabdomyolysis (HP:0003201) | 3.28034575 |
| 38 | Abnormality of placental membranes (HP:0011409) | 3.24483721 |
| 39 | Amniotic constriction ring (HP:0009775) | 3.24483721 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.19495963 |
| 41 | Subaortic stenosis (HP:0001682) | 3.19495963 |
| 42 | Aplasia of the musculature (HP:0100854) | 3.18165782 |
| 43 | Sudden death (HP:0001699) | 3.16967979 |
| 44 | Bundle branch block (HP:0011710) | 3.13692432 |
| 45 | Gowers sign (HP:0003391) | 3.10491746 |
| 46 | Rimmed vacuoles (HP:0003805) | 2.90953996 |
| 47 | Type 2 muscle fiber atrophy (HP:0003554) | 2.86466812 |
| 48 | Hip contracture (HP:0003273) | 2.79942753 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.76315690 |
| 50 | Scapular winging (HP:0003691) | 2.61918951 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.59931261 |
| 52 | Muscle fiber atrophy (HP:0100295) | 2.58528758 |
| 53 | * Bulbar palsy (HP:0001283) | 2.50623805 |
| 54 | Facial diplegia (HP:0001349) | 2.49921271 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.47112633 |
| 56 | Shoulder girdle muscle weakness (HP:0003547) | 2.45620521 |
| 57 | Pelvic girdle muscle weakness (HP:0003749) | 2.44970798 |
| 58 | Akinesia (HP:0002304) | 2.43511107 |
| 59 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.41818012 |
| 60 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.41818012 |
| 61 | * Generalized muscle weakness (HP:0003324) | 2.41049767 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.40395151 |
| 63 | * Dilated cardiomyopathy (HP:0001644) | 2.39096789 |
| 64 | Long clavicles (HP:0000890) | 2.36281667 |
| 65 | Metatarsus adductus (HP:0001840) | 2.35216980 |
| 66 | * Weak cry (HP:0001612) | 2.32649364 |
| 67 | Limb-girdle muscle atrophy (HP:0003797) | 2.28608419 |
| 68 | * Mildly elevated creatine phosphokinase (HP:0008180) | 2.23559358 |
| 69 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.18036286 |
| 70 | Muscular dystrophy (HP:0003560) | 2.14109782 |
| 71 | Abnormality of the foot musculature (HP:0001436) | 2.14049952 |
| 72 | Proximal amyotrophy (HP:0007126) | 2.13444553 |
| 73 | Easy fatigability (HP:0003388) | 2.12950591 |
| 74 | * Frequent falls (HP:0002359) | 2.11951239 |
| 75 | Ulnar deviation of finger (HP:0009465) | 2.09303359 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.06629029 |
| 77 | Heart block (HP:0012722) | 2.05810567 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.04831672 |
| 79 | Hyperkalemia (HP:0002153) | 2.03934844 |
| 80 | Hypoplastic ischia (HP:0003175) | 2.01286563 |
| 81 | Trismus (HP:0000211) | 2.01197701 |
| 82 | Limb-girdle muscle weakness (HP:0003325) | 2.00001706 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 1.98166843 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 1.97410612 |
| 85 | Nonprogressive disorder (HP:0003680) | 1.97354062 |
| 86 | Pterygium (HP:0001059) | 1.95775843 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 1.94174137 |
| 88 | Hypoplastic heart (HP:0001961) | 1.93719109 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 1.93594523 |
| 90 | Limited hip movement (HP:0008800) | 1.92616797 |
| 91 | Thin ribs (HP:0000883) | 1.90802553 |
| 92 | * EMG: neuropathic changes (HP:0003445) | 1.89646959 |
| 93 | Exercise intolerance (HP:0003546) | 1.89202911 |
| 94 | Breech presentation (HP:0001623) | 1.86586247 |
| 95 | Lipoatrophy (HP:0100578) | 1.83988658 |
| 96 | Tarsal synostosis (HP:0008368) | 1.81179767 |
| 97 | Lower limb amyotrophy (HP:0007210) | 1.80192236 |
| 98 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.79814634 |
| 99 | * Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79672143 |
| 100 | * Spinal rigidity (HP:0003306) | 1.78844566 |
| 101 | Ventricular arrhythmia (HP:0004308) | 1.77821099 |
| 102 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.77336459 |
| 103 | Abnormality of the ischium (HP:0003174) | 1.74294502 |
| 104 | Paralysis (HP:0003470) | 1.72473734 |
| 105 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.72193714 |
| 106 | Webbed neck (HP:0000465) | 1.68544539 |
| 107 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.68488761 |
| 108 | * Waddling gait (HP:0002515) | 1.66783482 |
| 109 | Increased intramyocellular lipid droplets (HP:0012240) | 1.66767827 |
| 110 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.62589290 |
| 111 | Synostosis involving bones of the feet (HP:0009140) | 1.62589290 |
| 112 | Increased muscle lipid content (HP:0009058) | 1.54287740 |
| 113 | Adducted thumb (HP:0001181) | 1.34122943 |
| 114 | Steppage gait (HP:0003376) | 1.33494219 |
| 115 | Generalized amyotrophy (HP:0003700) | 1.28425088 |
| 116 | Ventricular fibrillation (HP:0001663) | 1.25562559 |
| 117 | Short palpebral fissure (HP:0012745) | 1.23715333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.52618169 |
| 2 | TTN | 5.85274245 |
| 3 | PIK3CG | 5.32402595 |
| 4 | PHKG2 | 4.22042683 |
| 5 | PHKG1 | 4.22042683 |
| 6 | NME1 | 3.11347185 |
| 7 | MUSK | 2.75884488 |
| 8 | TRIB3 | 2.64127443 |
| 9 | MAP2K3 | 2.38518886 |
| 10 | NEK1 | 1.98437355 |
| 11 | DMPK | 1.91948606 |
| 12 | PDK3 | 1.84307983 |
| 13 | PDK4 | 1.84307983 |
| 14 | MAP3K7 | 1.76928486 |
| 15 | PIK3CA | 1.59203052 |
| 16 | MAPK12 | 1.56585574 |
| 17 | PINK1 | 1.51878120 |
| 18 | PKN2 | 1.31549172 |
| 19 | MAPKAPK3 | 1.31209466 |
| 20 | MOS | 1.28701036 |
| 21 | BCKDK | 1.18867433 |
| 22 | PDK2 | 1.14685096 |
| 23 | MAP2K4 | 1.12647490 |
| 24 | MAP2K6 | 0.99875780 |
| 25 | MARK1 | 0.98185713 |
| 26 | MAP3K3 | 0.97803438 |
| 27 | CCNB1 | 0.88108513 |
| 28 | ILK | 0.80656861 |
| 29 | TRPM7 | 0.79019996 |
| 30 | EPHB1 | 0.77356974 |
| 31 | AKT2 | 0.77291600 |
| 32 | RIPK1 | 0.76662715 |
| 33 | MAP3K13 | 0.71215344 |
| 34 | STK24 | 0.70546511 |
| 35 | LIMK1 | 0.69227096 |
| 36 | PRKAA1 | 0.63558977 |
| 37 | CAMK4 | 0.60568068 |
| 38 | MAP3K10 | 0.60061805 |
| 39 | EEF2K | 0.60031658 |
| 40 | SIK1 | 0.57885067 |
| 41 | MAPK11 | 0.57766976 |
| 42 | PRKAA2 | 0.56078251 |
| 43 | ROCK1 | 0.55671728 |
| 44 | CAMK2G | 0.55660524 |
| 45 | ZAK | 0.55073769 |
| 46 | MAP2K1 | 0.54592368 |
| 47 | MAP3K5 | 0.54528653 |
| 48 | NEK9 | 0.54284390 |
| 49 | PIM2 | 0.50230808 |
| 50 | TAOK2 | 0.46681422 |
| 51 | PTK6 | 0.46122813 |
| 52 | TAOK1 | 0.45711344 |
| 53 | MAP3K11 | 0.41951073 |
| 54 | ICK | 0.41698761 |
| 55 | CAMK1 | 0.41562448 |
| 56 | SGK3 | 0.41096975 |
| 57 | CAMK2B | 0.40998058 |
| 58 | ROCK2 | 0.39485048 |
| 59 | ERN1 | 0.37105174 |
| 60 | ERBB3 | 0.36249259 |
| 61 | PRKG1 | 0.35953345 |
| 62 | MYLK | 0.35017031 |
| 63 | ARAF | 0.34764145 |
| 64 | DYRK1B | 0.34481263 |
| 65 | PRKD1 | 0.30966771 |
| 66 | TBK1 | 0.30278045 |
| 67 | LATS2 | 0.30182560 |
| 68 | PRKACB | 0.29794555 |
| 69 | DDR2 | 0.29254158 |
| 70 | TIE1 | 0.28252511 |
| 71 | CDK19 | 0.27407478 |
| 72 | PRPF4B | 0.27137736 |
| 73 | RPS6KA3 | 0.26627300 |
| 74 | LRRK2 | 0.26437588 |
| 75 | SGK2 | 0.24904457 |
| 76 | LATS1 | 0.24784014 |
| 77 | MAPK13 | 0.24570791 |
| 78 | PDGFRA | 0.24513631 |
| 79 | RPS6KB1 | 0.24233717 |
| 80 | FER | 0.23840804 |
| 81 | PAK4 | 0.23768351 |
| 82 | SGK1 | 0.23292458 |
| 83 | PKN1 | 0.23093678 |
| 84 | MAPK4 | 0.21822056 |
| 85 | MTOR | 0.21341087 |
| 86 | MAPK7 | 0.21082570 |
| 87 | PDPK1 | 0.20096543 |
| 88 | KSR2 | 0.19813896 |
| 89 | PTK2B | 0.19455074 |
| 90 | RPS6KL1 | 0.18527351 |
| 91 | RPS6KC1 | 0.18527351 |
| 92 | TGFBR2 | 0.18493423 |
| 93 | CAMK2D | 0.18112925 |
| 94 | PRKACA | 0.17678374 |
| 95 | DAPK3 | 0.16688275 |
| 96 | MAP3K1 | 0.16060067 |
| 97 | EPHB2 | 0.15717128 |
| 98 | CDK6 | 0.15384621 |
| 99 | MARK2 | 0.15230031 |
| 100 | MAP3K6 | 0.14758707 |
| 101 | BRAF | 0.14152636 |
| 102 | RPS6KA6 | 0.13718583 |
| 103 | RAF1 | 0.13446679 |
| 104 | FGFR1 | 0.13332245 |
| 105 | RPS6KB2 | 0.12378426 |
| 106 | MAP3K9 | 0.12333976 |
| 107 | PRKACG | 0.11554749 |
| 108 | DAPK2 | 0.11418613 |
| 109 | CAMK2A | 0.10954670 |
| 110 | PDK1 | 0.10023894 |
| 111 | ZAP70 | 0.09373076 |
| 112 | STK38L | 0.09180683 |
| 113 | CDK14 | 0.08225747 |
| 114 | FLT3 | 0.08052981 |
| 115 | SGK223 | 0.07920731 |
| 116 | SGK494 | 0.07920731 |
| 117 | MAPKAPK2 | 0.07880943 |
| 118 | PAK6 | 0.07136325 |
| 119 | KSR1 | 0.07045933 |
| 120 | BMX | 0.06784894 |
| 121 | RPS6KA1 | 0.05676398 |
| 122 | MARK3 | 0.05101176 |
| 123 | RPS6KA2 | 0.05058386 |
| 124 | CDC42BPA | 0.04881918 |
| 125 | RET | 0.04703948 |
| 126 | CDK15 | 0.04066504 |
| 127 | MAPK10 | 0.03886516 |
| 128 | MAPK9 | 0.03817836 |
| 129 | STK11 | 0.03453893 |
| 130 | INSRR | 0.02996280 |
| 131 | MAPK8 | 0.02823427 |
| 132 | CSNK1D | 0.02511351 |
| 133 | CDK11A | 0.01971803 |
| 134 | GSK3B | 0.01752184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 5.08615191 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.52655482 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.30595371 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.27603843 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.25265415 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.21732369 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.32239045 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07034436 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.05913956 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03436879 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.97321988 |
| 12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.89585901 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88055003 |
| 14 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.87075800 |
| 15 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.86412196 |
| 16 | Tight junction_Homo sapiens_hsa04530 | 1.82877728 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71823505 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70862303 |
| 19 | Insulin resistance_Homo sapiens_hsa04931 | 1.68433758 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.57778447 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.57314821 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.54099643 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45002567 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39253681 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.38522587 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35667432 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34365340 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32284405 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.31603598 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.31167507 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.30620354 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22163219 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17096679 |
| 34 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15863606 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.09545680 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06471774 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02426592 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98540105 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98258896 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97976406 |
| 41 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92972866 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88448013 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85156632 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84772858 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83603560 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83439661 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80764512 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80296573 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74418258 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.74112542 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74069540 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73888379 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.70433928 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69731187 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69104334 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68887581 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66991308 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63830125 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62397789 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.62061042 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60126691 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58235536 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56394909 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53522782 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.52766480 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52636810 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51439709 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48514798 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.48269851 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44795606 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38872649 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37708731 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.37463223 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.34074391 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33231442 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30983164 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30864813 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28620668 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28387389 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.28258135 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28179613 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27612146 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26884020 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25227806 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.24574929 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23808699 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.23472936 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.22798187 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.22258546 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21833938 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.21416764 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.20639975 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.18246769 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18194458 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17093733 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.16385662 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16264962 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15929884 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14451121 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.14362646 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14271808 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.14089933 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.13722450 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13421917 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13106256 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13002391 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.12912218 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.11968660 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.11251807 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.10300993 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09510135 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.09380468 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.09344889 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08822952 |
| 115 | Circadian entrainment_Homo sapiens_hsa04713 | 0.08808683 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08774827 |
| 117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08387600 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.08348085 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.08148884 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07460478 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.07167799 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.06149196 |
| 123 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05547617 |

